|
Atomistry » Sodium » PDB 8oyg-8pha » 8ph4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Sodium » PDB 8oyg-8pha » 8ph4 » |
Sodium in PDB 8ph4: Co-Crystal Structure of the Sars-COV2 Main Protease NSP5 with An Uracil-Carrying X77-Like InhibitorEnzymatic activity of Co-Crystal Structure of the Sars-COV2 Main Protease NSP5 with An Uracil-Carrying X77-Like Inhibitor
All present enzymatic activity of Co-Crystal Structure of the Sars-COV2 Main Protease NSP5 with An Uracil-Carrying X77-Like Inhibitor:
3.4.22.69; Protein crystallography data
The structure of Co-Crystal Structure of the Sars-COV2 Main Protease NSP5 with An Uracil-Carrying X77-Like Inhibitor, PDB code: 8ph4
was solved by
T.Barthel,
N.Altincekic,
N.Jores,
J.Wollenhaupt,
M.S.Weiss,
H.Schwalbe,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Sodium Binding Sites:
The binding sites of Sodium atom in the Co-Crystal Structure of the Sars-COV2 Main Protease NSP5 with An Uracil-Carrying X77-Like Inhibitor
(pdb code 8ph4). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 2 binding sites of Sodium where determined in the Co-Crystal Structure of the Sars-COV2 Main Protease NSP5 with An Uracil-Carrying X77-Like Inhibitor, PDB code: 8ph4: Jump to Sodium binding site number: 1; 2; Sodium binding site 1 out of 2 in 8ph4Go back to Sodium Binding Sites List in 8ph4
Sodium binding site 1 out
of 2 in the Co-Crystal Structure of the Sars-COV2 Main Protease NSP5 with An Uracil-Carrying X77-Like Inhibitor
Mono view Stereo pair view
Sodium binding site 2 out of 2 in 8ph4Go back to Sodium Binding Sites List in 8ph4
Sodium binding site 2 out
of 2 in the Co-Crystal Structure of the Sars-COV2 Main Protease NSP5 with An Uracil-Carrying X77-Like Inhibitor
Mono view Stereo pair view
Reference:
N.Altincekic,
N.Jores,
F.Lohr,
C.Richter,
C.Ehrhardt,
M.J.J.Blommers,
H.Berg,
S.Ozturk,
S.L.Gande,
V.Linhard,
J.Orts,
M.J.Abi Saad,
M.Butikofer,
J.Kaderli,
B.G.Karlsson,
U.Brath,
M.Hedenstrom,
G.Grobner,
U.H.Sauer,
A.Perrakis,
J.Langer,
L.Banci,
F.Cantini,
M.Fragai,
D.Grifagni,
T.Barthel,
J.Wollenhaupt,
M.S.Weiss,
A.Robertson,
A.Bax,
S.Sreeramulu,
H.Schwalbe.
Targeting the Main Protease (M Pro , NSP5) By Growth of Fragment Scaffolds Exploiting Structure-Based Methodologies. Acs Chem.Biol. 2024.
Page generated: Wed Oct 9 12:56:25 2024
ISSN: ESSN 1554-8937 PubMed: 38232960 DOI: 10.1021/ACSCHEMBIO.3C00720 |
Last articlesZn in 9FS1Zn in 9FS3 Zn in 9FS2 Zn in 9H3H Zn in 9F29 Zn in 9F2A Zn in 9EY2 Zn in 9F26 Zn in 9E8J Zn in 9E8N |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |